Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Medtronic
Chinese Patent Office
Johnson and Johnson
Harvard Business School
Merck
Fish and Richardson
Accenture
Cerilliant

Generated: January 23, 2019

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of cholestyramine patent protection?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Zydus Pharms Usa Inc, Teva Pharms, Upsher Smith Labs, Bristol Myers, and Apothecon, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Eight suppliers are listed for this compound.

Pharmacology for cholestyramine
Synonyms for cholestyramine
CHEMBL2110633
HGMSJMJPXGGEBP-UHFFFAOYSA-N

US Patents and Regulatory Information for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers QUESTRAN LIGHT cholestyramine POWDER;ORAL 019669-003 Dec 5, 1988 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc CHOLESTYRAMINE LIGHT cholestyramine POWDER;ORAL 202902-001 Apr 25, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc CHOLESTYRAMINE cholestyramine POWDER;ORAL 074554-002 Oct 2, 1996 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Apothecon QUESTRAN cholestyramine TABLET;ORAL 073403-001 Apr 28, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071621-001 May 26, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Parke Davis CHOLYBAR cholestyramine BAR, CHEWABLE;ORAL 071739-001 May 26, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Chubb
Daiichi Sankyo
Moodys
UBS
Boehringer Ingelheim
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.